Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
企業コードFTRE
会社名Fortrea Holdings Inc
上場日Jun 16, 2023
最高経営責任者「CEO」Mr. Anshul Thakrala
従業員数15500
証券種類Ordinary Share
決算期末Jun 16
本社所在地8 Moore Drive
都市DURHAM
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号27709
電話番号18774950816
ウェブサイトhttps://www.fortrea.com/
企業コードFTRE
上場日Jun 16, 2023
最高経営責任者「CEO」Mr. Anshul Thakrala
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし